H4R antagonists also blocked the differentiation of Th17 cells in vitro and reduction in IL-17 production has also been reported in models of asthma and dermatitis (Dunford et al., 2006; Cowden et al., 2010b, 2014). This evidence concerns the gene HRH4 and skin disorder.